|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.71||1.27 (+2.07%)||47.55 - 70.54||5.9 million (Below Avg)|
Market data as of 4:01PM 10/12/15. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Expanded FDA Approval in Previously-Treated Metastatic Non-Small Cell Lung Cancer (NSCLC), Offering Improved Survival to More Patients
10/09/2015 3:02 PM ET